Research products
PT-141
EUR 34.95
Product Overview
Research use only
PT-141 is the research name commonly associated with bremelanotide, a cyclic melanocortin receptor agonist developed from melanocortin-peptide chemistry. Bremelanotide is an approved U.S. active ingredient under the brand Vyleesi for a specific indication, but a generic research vial should not be presented as equivalent to the approved finished drug product.
Product information
Research area: melanocortin receptor pharmacology, particularly central melanocortin pathways. The approved drug’s label describes bremelanotide as a melanocortin receptor agonist. For research material, exact salt form, sequence/cyclization state, purity and analytical identity should be documented independently from the branded medicine.